Procedures

This section covers the various facets of laboratory test procedures in TDM

General Principles of TDM Laboratory Test Procedures

  • Purpose: To accurately measure drug concentrations in biological samples to optimize therapy and minimize toxicity
  • Analytical Methods
    • Immunoassays: Based on antibody-antigen binding
    • Chromatography: Separates and quantifies drugs based on their properties
  • Sample Types
    • Serum, plasma, whole blood (depending on the drug)
  • Reporting Units
    • ng/mL, μg/mL, mg/L, etc

Immunoassay Methods

  • Principle
    • Utilizes specific antibodies to bind to the drug being measured
    • The antibody-drug complex is then detected and quantified
  • Types
    • Competitive Immunoassays: Drug in sample competes with labeled drug
    • Non-Competitive Immunoassays: Antibody binds directly to the drug
    • Homogeneous Immunoassays: No separation steps
    • Heterogeneous Immunoassays: Require separation steps
  • Examples
    • Enzyme-Multiplied Immunoassay Technique (EMIT)
    • Fluorescence Polarization Immunoassay (FPIA)
    • Chemiluminescent Microparticle Immunoassay (CMIA)
  • Advantages: High throughput, ease of use, and automation
  • Limitations: Potential for cross-reactivity, matrix effects, and interference from heterophile antibodies

Chromatographic Methods

  • Principle
    • Separates drugs and metabolites based on physical and chemical properties
    • Quantifies the separated compounds using various detectors
  • Types
    • High-Performance Liquid Chromatography (HPLC)
    • Liquid Chromatography-Mass Spectrometry (LC-MS/MS)
    • Gas Chromatography (GC)
  • Detectors
    • UV-Vis, fluorescence, mass spectrometry
  • Advantages: High specificity and sensitivity, ability to measure multiple drugs/metabolites simultaneously
  • Limitations: More complex, requires skilled operators, and more expensive than immunoassays

Special Precautions

  • Patient Preparation
    • Timing of dose: Collect samples at appropriate times (trough, peak)
    • Medication history: Document all medications and supplements
    • Fasting requirements: May be needed for some tests
  • Sample Collection
    • Use correct collection tubes
    • Follow the correct order of draw
    • Proper venipuncture technique to minimize hemolysis
    • Label specimens immediately and accurately
  • Sample Handling
    • Process promptly
    • Aliquot correctly
    • Store at correct temperature
    • Protect from light if necessary

Specimen Collection and Processing

  • Specimen Types: Serum, plasma, whole blood
  • Collection Tubes: SST, EDTA, heparin
  • Centrifugation: Centrifuge promptly after collection
  • Separation: Separate serum or plasma from cells within the specified time frame
  • Storage: Refrigerate or freeze samples at recommended temperatures

Troubleshooting

  • High Drug Results
    • Pre-analytical: Wrong collection time, medication administration error, contamination
    • Analytical: Incorrect calibration, reagent issues, interferences
  • Low Drug Results
    • Pre-analytical: Wrong collection time, degradation, improper storage
    • Analytical: Calibration issues, reagent problems, interferences
  • Inconsistent Results
    • Pre-analytical: Patient variability, handling errors
    • Analytical: Assay variability, interferences
  • Quality Control (QC) Failures
    • Pre-analytical: QC improperly stored or expired
    • Analytical: Calibration errors, reagent issues, instrument malfunction
    • Investigate and correct the source of the error

Interfering Substances

  • Hemolysis: Can interfere with immunoassays
  • Lipemia: Can cause turbidity and affect spectrophotometric assays
  • Bilirubin: Can interfere with spectrophotometric assays
  • Drugs: Other drugs can interfere with the assay or affect drug levels
  • Heterophile Antibodies: Can cause falsely high or low results
  • Cross-Reactivity: Antibodies may bind to other substances
  • Matrix Effects: Components in the sample matrix can affect results